The effects of oat β-glucan on the hypoglycemic of type 2 diabetic mice

2010 4th International Conference on Bioinformatics and Biomedical Engineering, iCBBE 2010

Volumn , Issue , 2010, Pages

  Shen, Ruiling ^a   Cai, Fengli ^a  

^a ZHENGZHOU INSTITUTE OF TECHNOLOGY   (China)

Author keywords

glucan; Blood glucose; Insulin; Keywords Oat ; Type 2 diabetes

Indexed keywords

-GLUCAN; ACTIVITY INDEX; BLOOD GLUCOSE; DIABETIC MICE; EFFECTIVE DOSE; GLUCOSE TOLERANCE; HIGH-FAT DIET; HYPOGLYCEMIC EFFECT; INSULIN SECRETION; MODEL GROUPS; NORMAL CONTROLS; OAT BRAN; ORAL ADMINISTRATION; ORAL GLUCOSE TOLERANCE TESTS; RANDOMIZED DESIGN; STREPTOZOTOCIN; TYPE-2 DIABETES;

BIOINFORMATICS; BLOOD; GLUCOSE; MEDICAL PROBLEMS; NUTRITION;

INSULIN;

EID: 77956134880     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1109/ICBBE.2010.5516500     Document Type: Conference Paper

References (5)

1. Jennifer A.Williams, Chron-Si Lai, Holly Corwin. Inclusion of Guar Gum and Alginate into a Crispy Bar Improves Postprandial Glycemia in Humans [J].J.Nutr.2004, 134:886-889.
2. Tapola N, Karvonen H, Niskanen L, Mikola M, Sarkkinen E. Glycemic responses of oat bran products in type 2 diabetic patients. Nutr Metab Cardiovasc Dis 2005; 15:255-61.
3. Reyna NY, Cano C, Bermudez VJ, Medina MT, Souki AJ, Ambard M, Nunez M, et al.. Sweeteners and beta-glucans improve metabolic and anthropometrics variables in well controlled type 2 diabetic patients. Am J Ther 2003; 10:43843.
4. Lovegrove JA, Clohessy A, Milon H, Williams CM. Modest doses of betaglucan do not reduce concentrations of potentially atherogenic lipoproteins. Am J Clin Nutr 2000; 72:49-55.
5. FDA, 1997. Final rule for food labelling: Health claims; Oats and coronary heart disease. Federal Regulations 62,3584-368.